Cancel
Known information
- Holds a PhD with a focus in health analytics from the School of Public Health at the University of North Carolina, Chapel Hill
- Has a master's degree in engineering management from Dartmouth College
- Previously worked as a consultant in the Pharmaceutical and Medical Products Practice at McKinsey & Co.
- Specialized in advising life science and healthcare clients on using AI and advanced analytics at McKinsey & Co.
- His academic research focused on applications of Bayesian network modeling methods to predicting and stratifying environmental human health risk
- Is a 2023 Healthcare Innovation 40 Under 40 Winner
- Has discussed using artificial intelligence to identify patients with generalized pustular psoriasis (GPP)
- Collaborated with the American Academy of Dermatology and Boehringer Ingelheim on AI projects
- Has completed work on using AI to identify patterns in real-world data for GPP diagnosis
- Serves as a subject matter expert and thought leader for OM1's AI work, including applications of the PhenOM digital phenotyping platform
About OM1
OM1 specializes in real-world data and AI for medical research and personalized medicine, offering solutions in real-world evidence, AI and predictive medicine, and outcomes measurement.
Report inaccurate information